Bernard, P.S.; Wooderchak-Donahue, W.; Wei, M.; Bray, S.M.; Wood, K.C.; Parikh, B.; McMillin, G.A.
Potential Utility of Pre-Emptive Germline Pharmacogenetics in Breast Cancer. Cancers 2021, 13, 1219.
https://doi.org/10.3390/cancers13061219
AMA Style
Bernard PS, Wooderchak-Donahue W, Wei M, Bray SM, Wood KC, Parikh B, McMillin GA.
Potential Utility of Pre-Emptive Germline Pharmacogenetics in Breast Cancer. Cancers. 2021; 13(6):1219.
https://doi.org/10.3390/cancers13061219
Chicago/Turabian Style
Bernard, Philip S., Whitney Wooderchak-Donahue, Mei Wei, Steven M. Bray, Kevin C. Wood, Baiju Parikh, and Gwendolyn A. McMillin.
2021. "Potential Utility of Pre-Emptive Germline Pharmacogenetics in Breast Cancer" Cancers 13, no. 6: 1219.
https://doi.org/10.3390/cancers13061219
APA Style
Bernard, P. S., Wooderchak-Donahue, W., Wei, M., Bray, S. M., Wood, K. C., Parikh, B., & McMillin, G. A.
(2021). Potential Utility of Pre-Emptive Germline Pharmacogenetics in Breast Cancer. Cancers, 13(6), 1219.
https://doi.org/10.3390/cancers13061219